Articles From: Akamai Releases Third Quarter, 2013 'State of the Internet' Report to Akers Biosciences Announces Its Financial Results for Fiscal 2013


2014/1/28
- Observed attack traffic originating from Indonesia drops; China returns to top of list - Global average and average peak connection speeds up 29 and 13 percent, respectively, year-over-year - More than 760 million unique IPv4 addresses connected to the Akamai Intelligent Platform CAMBRIDGE, Mass.
Sign-up for Akamai Releases Third Quarter, 2013 'State of the Internet' Report investment picks
2014/2/5
CAMBRIDGE, Mass.
Sign-up for Akamai Reports Record Fourth Quarter 2013 And Full-Year 2013 Financial Results investment picks
CAMBRIDGE, Mass.
Sign-up for Akamai Reports Third Quarter 2013 Financial Results investment picks
2013/10/23
SAN FRANCISCO (MarketWatch) -- Akamai Technologies Inc. (AKAM) on Wednesday reported a third-quarter profit of $80 million, or 44 cents a share, on $396 million in revenue.
Sign-up for Akamai Tech earnings rise to $80 million investment picks
2013/10/30
Cloud services provider recognized for financial performance, leadership in corporate sustainability CAMBRIDGE, Mass.
Sign-up for Akamai Technologies Named to Dow Jones Sustainability Index North America investment picks
CAMBRIDGE, Mass.
Sign-up for Akamai Technologies To Participate In The Citi Global Technology Conference investment picks
2013/11/27
CAMBRIDGE, Mass.
Sign-up for Akamai Technologies To Participate In The Credit Suisse Annual Technology Conference investment picks
2014/2/6
CAMBRIDGE, Mass.
Sign-up for Akamai Technologies to Participate in the Goldman Sachs Technology and Internet Conference investment picks
2014/2/26
CAMBRIDGE, Mass.
Sign-up for Akamai Technologies To Participate In The Morgan Stanley Technology, Media And Telecom Conference investment picks
CAMBRIDGE, Mass.
Sign-up for Akamai Technologies to Participate in the UBS Global Technology Conference investment picks
2013/9/3
ADVISORY, Sept.
Sign-up for Akamai Technologies, Inc. [AKAM] to Ring The NASDAQ Stock Market Opening Bell investment picks
2013/12/2
CAMBRIDGE, Mass.
Sign-up for Akamai to Acquire Prolexic investment picks
2013/9/19
CAMBRIDGE, Mass.
Sign-up for Akamai to Gather Business and Technology Leaders at Sixth Annual Customer Conference investment picks
2014/4/3
CAMBRIDGE, Mass.
Sign-up for Akamai to Hold First Quarter 2014 Investor Conference Call on Thursday, May 1st at 4:30 PM ET investment picks
2014/2/3
CAMBRIDGE, Mass.
Sign-up for Akamai To Host 2014 Investor Summit investment picks
2013/10/9
Designed to bolster an ecosystem of innovation for developers, customers and partners CAMBRIDGE, Mass.
Sign-up for Akamai Unveils Open Platform Initiative at Akamai Edge 2013 Customer Conference investment picks
2013/12/18
Unique Mobile Optimizations, Faster Performance, and Greater Visibility and Control Hallmarks of Latest Akamai Web Experience Solutions Technology CAMBRIDGE, Mass.
Sign-up for Akamai Ups the Ante for Optimized Web Performance and Control investment picks
2014/2/20
Conference Program Sessions, Live Attack Defense Demonstrations Key Aspects of Event Participation CAMBRIDGE, Mass.
Sign-up for Akamai's Web Security Thought Leadership and Technology Expertise to be Highlighted at RSA Conference 2014 investment picks
Agilysys, Inc. (Nasdaq: AGYS), a leading provider of innovative information technology and hospitality software and services, today announced that Akaryn Hospitality Management Services (AHMS) has selected the Agilysys Eatec® inventory and procurement system and the Agilysys InfoGenesis™ POS system to streamline operations at Thailand's Aleenta Phuket-Phang Nga Resort and Spa.
Sign-up for Akaryn Hospitality Management Services Selects Agilysys Solution Suite investment picks
2014/2/5
By Yeliz Candemir ISTANBUL--Akbank TAS (AKBNK.IS), Turkey's second-largest bank by market value, Wednesday posted a 45% drop in its fourth-quarter net profit, due to foreign exchange losses on a weak lira and short- term swap costs.
Sign-up for Akbank fourth-Quarter Profit Falls Short of Expectations investment picks
As one of the world’s leading dog shows, the 2013 AKC/Eukanuba National Championship continues to innovate inside and outside of the ring by offering livestream of the entire event with cutting-edge social capabilities.
Sign-up for AKC/Eukanuba National Championship Takes Dog Shows to New Level with Interactive Livestreaming investment picks
2014/3/26
Akebia Therapeutics, Inc. (NASDAQ:AKBA), a biopharmaceutical company focused on the development of novel, proprietary therapeutics based on hypoxia-inducible factor biology and the commercialization of these products for patients with kidney disease, today announced the closing of its initial public offering of 6,762,000 shares of common stock at an initial public offering price of $17.00 per share.
Sign-up for Akebia Therapeutics Announces Closing of Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares investment picks
2014/3/20
Akebia Therapeutics, Inc. today announced the pricing of its initial public offering of 5,882,353 shares of common stock at an initial public offering price of $17.00 per share.
Sign-up for Akebia Therapeutics Announces Pricing of Initial Public Offering investment picks
2014/1/30
http://media.marketwire.com/attachments/201401/219880_NNMF_logo_v3.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1085761&ProfileId=051205&sourceType=1 HOUSTON, TX --
Sign-up for Aker BioMarine Manufacturing Closes $28 Million in NMTC Financing for New Houston Production Facility investment picks
2014/3/28
THOROFARE, N.J., March 28, 2014 (GLOBE NEWSWIRE) -- Akers Biosciences, Inc. (AKR.L) (Nasdaq:AKER) , (the "Company" or "Akers"), a leading designer and manufacturer of rapid diagnostic screening and testing products, reports its financial results for the fiscal year ended December 31, 2013.
Sign-up for Akers Biosciences Announces Its Financial Results for Fiscal 2013 investment picks
Start Premium Trial Register For Free

P F Fund Financial Data (13,000+ funds)
P F Stock Financial Data (7,000+ stocks)
P F Stock and Fund Screeners (basic)
P F Investing Articles and Market Commentary
P F Articles Archive (>30 days)
P F Discuss (dozens of stock, fund, bond, and general bulletin boards)
P F Portfolio Manager (basic)
P F Morningstar Investment Classroom
P F Access Your Portfolio Anytime, Anywhere via Your Mobile Device
P   Morningstar Fund Analyst Reports (full research on 1,700 funds, ETFs, and CEFs)
P   Morningstar Stock Analyst Reports (full research on more than 1,100 stocks)
P   Portfolio Manager (advanced with 10 X-Ray analyses, including recommendations)
P   Portfolio Monitor (monthly and on-demand personalized portfolio statements)
P   Morningstar Proprietary Stock Information (stock star ratings, buy/sell prices, economic moat ratings, and more)
P   Morningstar 5-Star Stock and Fund Favorites & Red Flags eNewsletters
P   Premium Stock and Fund Screeners (advanced with nearly infinite ways to find the best securities for you)
P   Discounts on Morningstar newsletters, books, seminars, and more

Sign-up to Morningstar


Basic Access

Articles and Videos
Morningstar video reports, articles, data, and tools. Dig into our lineup of e-newsletters and investing classroom courses outlining sensible strategies for maximizing your investments.
Morningstar Discuss
Follow the buzz on individual stocks or fund families. Plus, read the latest posts from Morningstar members and analysts.
Portfolio Manager
Track your investments and watch lists with our Portfolio Manager. Customize your view with our comprehensive stock, fund, and ETF data.

Access these features and more when you sign up for Free Membership.
Join Morningstar today. It's Free.

Unlimited Access

Analyst Research
Gather in-depth, actionable insight on over 3,700 stock and mutual funds covered by Morningstar analysts. View our mutual fund Analyst Reports favored by professionals, savvy experienced investors, and new investors researching options for retirement savings, college plans, or other investment needs.
Portfolio X-Ray®
Ensure your portfolio is positioned exactly how you want with Morningstar's X-Ray Interpreter and Stock Intersection tools. A Barron's "Best of the Web" award winner for five years running, X-Ray Interpreter goes under the hood of your portfolio to provide a useful allocation, sector, and geographic analysis. And you can discover how much of a stock you really own, individually and through mutual funds, with Stock Intersection.
Investment Picks
Find new 5-star stocks (greatly undervalued companies) to consider daily. Our 5-star stock rating is a proven winner, consistently beating benchmarks like the S&P 500. Plus, browse our Fund Analyst Picks and Stewardship Grades to find shareholder-friendly mutual funds that are poised for outperformance.
Portfolio Monitor
Get a clear view of your investments with personalized reports about your portfolio. Receive monthly statements and generate reports on-demand to help you stay on track to meet your investment goals.

Access these features and more when you sign up for Premium Membership.
Start your free 14-day trial today online
Your subscription may be tax deductible. Please contact your tax advisor.

Articles From: Akamai Releases Third Quarter, 2013 'State of the Internet' Report to Akers Biosciences Announces Its Financial Results for Fiscal 2013
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity